A study by University of Liverpool scientists found that the initial treatment for a brain infection caused by fungus could now be treated in three days, rather than two weeks.
Cryptococcus - a form of yeast - infections are often fatal but are relatively neglected in medical research. They are found in many parts of the world, including Africa, Australasia and South East Asia and mainly affect people with weakened immune systems. This infection kills up to 700,000 people a year.
Family of Boy With Rare Brain Infection Decides to Donate His Organs
The organs' of a 12 year-old boy, who could not survive a rare and deadly infection caused by brain eating amoeba, will be donated, his family confirmed.
Advertisement
The University research team has tested the effects of the most commonly used drug on Cryptococcus infections of the brain and discovered that although the recommendation for treatment is currently two weeks, the drug has been shown by the new studies to be effective at clearing the fungus within three days.
Professor of Therapeutics and Infectious Diseases, William Hope said: "This infection kills up to 700,000 people a year and is mainly fatal in areas with poor resources. In many parts of the world it is simply infeasible to administer intravenous drugs for two weeks."
![Scientists: Material in Dissolvable Sutures Could Treat Brain Infections And Reduce Hospital Stays]( "Scientists: Material in Dissolvable Sutures Could Treat Brain Infections And Reduce Hospital Stays")
Scientists report that a plastic material already used in absorbable surgical sutures shows promise for continuous administration of antibiotics to patients with brain infections.
The scientists in the Institute of Translational Medicine examined the effects of amphotericin B deoxycholate (dAmB) over both three and 14 day treatments and found that the effect was the same after three days as it was after two weeks.
The results in animal trials was compared with humans using a range of mathematical modelling techniques, to produce findings which suggest that the three day regime will be equally as effective in people.
The researchers believe that this opens up significant possibilities for treatment in areas where there is a scarcity of medically trained staff, who often have to ration the drugs they administer to patients.
The infection often takes hold in people with AIDS as a result of their immune systems being compromised, and areas with high rates of AIDS are also usually those without resources.
Professor Hope added: "A lot of the treatment administered with a variety of drugs is assumed and generalised. This is one example of how experimental medicine can help accelerate changes to improve outcomes for patients."
The next stage of the research will be to test it in clinical trials in humans. The findings were published in the journal mBio.
Source: Eurekalert
Scientists: Material in Dissolvable Sutures Could Treat Brain Infections And Reduce Hospital Stays
Scientists report that a plastic material already used in absorbable surgical sutures shows promise for continuous administration of antibiotics to patients with brain infections.
Advertisement
The scientists in the Institute of Translational Medicine examined the effects of amphotericin B deoxycholate (dAmB) over both three and 14 day treatments and found that the effect was the same after three days as it was after two weeks.
The results in animal trials was compared with humans using a range of mathematical modelling techniques, to produce findings which suggest that the three day regime will be equally as effective in people.
The researchers believe that this opens up significant possibilities for treatment in areas where there is a scarcity of medically trained staff, who often have to ration the drugs they administer to patients.
The infection often takes hold in people with AIDS as a result of their immune systems being compromised, and areas with high rates of AIDS are also usually those without resources.
Professor Hope added: "A lot of the treatment administered with a variety of drugs is assumed and generalised. This is one example of how experimental medicine can help accelerate changes to improve outcomes for patients."
The next stage of the research will be to test it in clinical trials in humans. The findings were published in the journal mBio.
Source: Eurekalert
Study Finds Climate's Impact on Brain Infections in Sub-Saharan Africa
A team of researchers have found that the amount of rainfall impacts the number of infant infections leading to hydrocephalus in Uganda.
Advertisement
 Fatal Brain Infections can be Resolved by Singapore NanotechnologyNovel peptide nanoparticles developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN) of Singapore | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.